UK stops recruitment to hydroxychloroquine COVID-19 trials

The UK's drugs regulator has suspended recruitment to COVID-19 trials involving the drug hydroxychloroquine, saying that a review of study data did not provide evidence of any meaningful mo

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS). 

Large UK hospital to tear up paper records amid digitisation...

A hospital in the UK is preparing to scrap its old paper records and replace them with a new digital system that aims to improve efficiency.

MHRA says Avastin can be used for AMD despite Bayer, Novarti...

Conference brochure for the inaugural Respiratory Drug Deliv...

Conference brochure for the inaugural Respiratory Drug

Working with EU is 'preferred option' post-Brexit says MHRA ...

The outgoing chief executive of the UK’s drugs regulator has said that the country’s “preferred option” is to continue working with the European regulator after Brexit – although there are